EUVIMEDEUVIMED entdecken
Crossref

Reassessing the 8 cm Cutoff: Continuous Tumor Size‐Mortality Risk Supports Three‐Tier Staging in High Grade Osteosarcoma

Ezekiel Dingle iD, Kole Joachim, Othneil Sparks, Adrian Lin, Brandon Gettleman, Christopher Hamad, Casey Abernethy, Michael Fice, Nicholas M Bernthal iD, Alexander B Christ iD

Journal of Surgical Oncology · 2025

DOI: 10.1002/jso.70181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2025. Verfasst von Ezekiel Dingle und 9 weiteren Autor:innen. Beteiligte Einrichtung: David Geffen School of Medicine at the University of California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Osteosarcoma, Bone Neoplasms. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives Primary tumor size is a key prognostic factor in osteosarcoma, but quantitative risk estimates and optimal thresholds remain undefined. We quantified the size‐survival relationship in high‐grade osteosarcoma.

Methods

We analyzed 1,807 high‐grade osteosarcoma patients from the Surveillance, Epidemiology, and End Results (SEER) database (2000–2021) using Cox regression, systematic threshold testing (40–150 mm with multiple testing corrections), and propensity score matching at the AJCC 80 mm threshold.

Results

Each 10 mm increase in tumor size was associated with a 6.6% increased hazard of death after adjusting for age, sex, tumor site, surgery, radiation, and chemotherapy (Hazard ratio [HR] = 1.066, p < 0.001; adjusted C‐index = 0.694). Binary AJCC staging demonstrated limited mortality discrimination (34.4% vs 44.4%, 10‐percentage‐point spread), while three‐tier soft tissue sarcoma (STS)‐adapted staging revealed a 21‐percentage‐point mortality gradient (26.6% to 47.7%) with superior adjusted discrimination (C‐index = 0.695 vs 0.680, p < 0.001). All tested thresholds demonstrated significant associations, with no single optimal cutpoint identified. Polynomial testing indicated a linear relationship ( p = 0.334). Propensity score matching at the AJCC 8 cm threshold of 666 patient pairs confirmed the effect (HR = 1.443, 95%‐confidence interval: 1.214–1.715, p < 0.001). Polynomial testing indicated a linear relationship ( p = 0.253).

Conclusion

Tumor size demonstrates a continuous dose‐response relationship with survival. Three‐tier STS staging outperforms binary AJCC classification for risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaBone NeoplasmsHumansMaleFemaleNeoplasm StagingSEER ProgramAdultYoung AdultSurvival RateAdolescentPrognosisMiddle AgedChildNeoplasm GradingTumor BurdenFollow-Up StudiesPropensity ScoreAged

Autor:innen und Institutionen

  • David Geffen School of Medicine at the University of California, Los Angeles, California, USA.
  • Department of Orthopaedic Surgery, University of California, Los Angeles, California, USA.
  • Department of Orthopaedic Surgery, Greater Los Angeles VA Medical Center, Los Angeles, California, USA.

ORCID-Profile: Ezekiel Dingle, Nicholas M Bernthal, Alexander B Christ

Zitieren

APA

Dingle, E., Joachim, K., Sparks, O., Lin, A., Gettleman, B., Hamad, C., Abernethy, C., Fice, M., Bernthal, N. M., & Christ, A. B. (2025). Reassessing the 8 cm Cutoff: Continuous Tumor Size‐Mortality Risk Supports Three‐Tier Staging in High Grade Osteosarcoma. Journal of Surgical Oncology. https://doi.org/10.1002/jso.70181

Vancouver

Dingle E, Joachim K, Sparks O, Lin A, Gettleman B, Hamad C, et al. Reassessing the 8 cm Cutoff: Continuous Tumor Size‐Mortality Risk Supports Three‐Tier Staging in High Grade Osteosarcoma. Journal of Surgical Oncology. 2025. doi:10.1002/jso.70181

BibTeX
@article{Dingle2025,
  author = {Dingle, Ezekiel and Joachim, Kole and Sparks, Othneil and Lin, Adrian and Gettleman, Brandon and Hamad, Christopher and Abernethy, Casey and Fice, Michael and Bernthal, Nicholas M and Christ, Alexander B},
  title = {Reassessing the 8 cm Cutoff: Continuous Tumor Size‐Mortality Risk Supports Three‐Tier Staging in High Grade Osteosarcoma},
  journal = {Journal of Surgical Oncology},
  year = {2025},
  doi = {10.1002/jso.70181}
}
Kostenlos starten →